ΦΣ Ροδόπης, παρουσίαση Δαγρέ, 11-5-2013

download ΦΣ Ροδόπης, παρουσίαση Δαγρέ, 11-5-2013

of 40

Transcript of ΦΣ Ροδόπης, παρουσίαση Δαγρέ, 11-5-2013

  • 7/30/2019 , , 11-5-2013

    1/40

    (...-....)

    11 2013

    .. ...-....

  • 7/30/2019 , , 11-5-2013

    2/40

  • 7/30/2019 , , 11-5-2013

    3/40

    1.

    (72,4% , 2011 - 2013: 22,77%)

  • 7/30/2019 , , 11-5-2013

    4/40

    -2.1bn

    (-42%)

    Source: IOBE / SfEE, Facts & Figures 2012

  • 7/30/2019 , , 11-5-2013

    5/40

    Avg. EU, latest

    available data by

    OECD:320/capita

    Source:/SfEE , Facts & Fi gures 2012

  • 7/30/2019 , , 11-5-2013

    6/40

    ,(, & )

  • 7/30/2019 , , 11-5-2013

    7/40

    2012

  • 7/30/2019 , , 11-5-2013

    8/40

    2013 ()

  • 7/30/2019 , , 11-5-2013

    9/40

    2013 ()

    : 40%

    . . 2013: = 808 . = 13%

    . .

    0,6% , 2012

    . (. 2013) 3

  • 7/30/2019 , , 11-5-2013

    10/40

    2013 ()

    1 . , 7-4-2013

    . 300 .

    , 1 . 2013. (..: 3 2012).

    : , , .

  • 7/30/2019 , , 11-5-2013

    11/40

    1. (...)

  • 7/30/2019 , , 11-5-2013

    12/40

    12/2/2013 - - 214 (119 ,95 +). ( 235, 7-2-2013)

    ( 2-4-2012 11/2/2013) 812 (491 , 321 +). ( 1003, 2-4-2012)

    ,

    :1) 46,13 . / 2012,2) 46,68 . 1 2013,3) 2013 50+12=62 . .

    . 16-17% (2012 - . 2013).

  • 7/30/2019 , , 11-5-2013

    13/40

    2.

    (8,2% )

  • 7/30/2019 , , 11-5-2013

    14/40

    .... ( 284, 10-2-2004).

    1.284 , 115

    - 2 (. . 542/1-3-2012).

    5% ( 145 . ),8,2% ,

    22,5% (85 . .) (.: ....2012).

    ( ):1,70 /.

  • 7/30/2019 , , 11-5-2013

    15/40

    By populat ion : By number of pharmac ies :

    (..: ... .)

  • 7/30/2019 , , 11-5-2013

    16/40

    MARCH (1-3-2013)(Over-The-Counter-Medicin (OTC's),

    )

    OTCVOLTAREN EMULGEL 100 gr.

    (diclofenac)1 138% - 184% 258%

    OTCDEPON TB.

    (paracetamol 500mg)1 1.052,00% 208%

    OTCPANADOL COLD&FLU

    (paracetamol-pseudoefedrine)1 1.041,00%

    OTCPANADOL ADVANCE

    (paracetamol 500mg)1 1.224,00% 101,26%

    OTCPANADOL EXTRA ADVANCE

    (paracetamol-caffeine)1 764% 157%

    OTCASPIRIN tb. 500mg

    (acetylsalysic acid) 1 101,1% 166%

    OTCPONSTAN tb. 500mg

    (mefenamic acid)1 492% 192%

  • 7/30/2019 , , 11-5-2013

    17/40

    OTC ( ...) (.: IMS)

    1. OTC .2. , ,

    .3. OTC -

    .4. OTC

    .

  • 7/30/2019 , , 11-5-2013

    18/40

    .: OTC

    ....

  • 7/30/2019 , , 11-5-2013

    19/40

    Over-the-counter drug s also c ause many deaths.

    Every year, more than 15,000 patients di e in North Am erica

    f rom ord inary asp i r in and Ibupro fen.

    Paracetamol is the cause of thousands of hosp i ta l

    admiss ions and hund reds of deaths annual ly in North

    America.

    Terence Young, Member of Parliament for Oakville, Ontario, is the founder and Chair of Drug Safety

    Canada, a research and public advocacy organization based in Oakville.From article in To Your Health newsletter October 2011 by Citizens for Choice in Health Care

    Association, www.citizensforchoice.com

    http:/ /commonground.ca/2012/01/prescr ipt ion-drug-deaths/

    (..: ... ... (OTCs) ).

    http://www.citizensforchoice.com/http://commonground.ca/2012/01/prescription-drug-deaths/http://commonground.ca/2012/01/prescription-drug-deaths/http://commonground.ca/2012/01/prescription-drug-deaths/http://commonground.ca/2012/01/prescription-drug-deaths/http://commonground.ca/2012/01/prescription-drug-deaths/http://commonground.ca/2012/01/prescription-drug-deaths/http://www.citizensforchoice.com/
  • 7/30/2019 , , 11-5-2013

    20/40

    2.

    ... ;

  • 7/30/2019 , , 11-5-2013

    21/40

    2.

    ... ;

  • 7/30/2019 , , 11-5-2013

    22/40

  • 7/30/2019 , , 11-5-2013

    23/40

    3. ( .) -

    (9,4% )

  • 7/30/2019 , , 11-5-2013

    24/40

    . ( 1/ 127962/03/2004 395//27.2.2004, 10)

    5 , , , , , ,

    , 21

    . (, . 931/2010)

    7. , (advertorial, publi.). (, 55220-22/07/2009)

  • 7/30/2019 , , 11-5-2013

    25/40

  • 7/30/2019 , , 11-5-2013

    26/40

    1.-

  • 7/30/2019 , , 11-5-2013

    27/40

    1. ()

    , ( - - ).

    ( ).

    , :

    .

    .

    .

  • 7/30/2019 , , 11-5-2013

    28/40

    1. ()

    : .

    . .

    .

    .

  • 7/30/2019 , , 11-5-2013

    29/40

    1. ()

    . .

    ,

    .

    ,

    , (. )

    (.-manager),

    ,

    .

  • 7/30/2019 , , 11-5-2013

    30/40

    1. ()

    ( ) :

    ) ,

    ) , , .

    :

    :

    , .

    :

    , , .

  • 7/30/2019 , , 11-5-2013

    31/40

    2.

  • 7/30/2019 , , 11-5-2013

    32/40

    2.

    ()

    :

    )

    ( ),

    )

    .

  • 7/30/2019 , , 11-5-2013

    33/40

    2.

    ()

    , :

    )

    ) ,

    ) 70-75%

    ( ),

    ,

    &

    - .

    , ,

    ,

    (..:

    ) (..:

    )

    -- .

    2

  • 7/30/2019 , , 11-5-2013

    34/40

    2.

    ()

    ,

    .

    ( -

    ).

    --- -

    .

    .

    .

  • 7/30/2019 , , 11-5-2013

    35/40

    3.

    (brand-name: PHARMACY)

  • 7/30/2019 , , 11-5-2013

    36/40

    3. ( & ) ()

    , .

    .

    (5

    ).

    ,

    (.

    , ).

  • 7/30/2019 , , 11-5-2013

    37/40

    3. ( & ) ()

    ,

    -

    ,

    ( ),

    -

    ,

    ,

    .

  • 7/30/2019 , , 11-5-2013

    38/40

    3. ( & ) ()

    :

    1) ,

    ,

    2) ,

    ,

    3)

    ,

    4)

    .

    5)

    -.

    , .

  • 7/30/2019 , , 11-5-2013

    39/40

    3. ( & ) ()

    :

    1)

    ,

    .

    2)

    (

    ),3) ,

    .

  • 7/30/2019 , , 11-5-2013

    40/40